Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Clinical Radiology|February 27, 2001
The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imagingM J Dobson, B M Carrington, C D Collins, et al.
European Journal of Radiology|March 22, 2015
Should abdominal sequences be included in prostate cancer MR staging studies?S H McEvoy, L P Lavelle, Y M Purcell, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 20, 2003
Intradermal radioisotope injection optimises sentinel lymph node identification in breast cancerF J Fleming, A D K Hill, D Kavanagh, et al.
Clinical Radiology|April 1, 1994
Observer variation in pattern type and extent of disease in fibrosing alveolitis on thin section computed tomography and chest radiographyC D Collins, A U Wells, D M Hansell, et al.
Irish Journal of Medical Science|March 20, 2012
Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centreV O Chan, J P Das, J F Gerstenmaier, et al.
Clinical Radiology|April 18, 2000
Relationship of MRI and clinical staging to outcome in invasive bladder cancer treated by radiotherapyP Robinson, C D Collins, W D Ryder, et al.
Clinical Radiology|February 17, 2016
Predictive value of PI-RADS classification in MRI-directed transrectal ultrasound guided prostate biopsyE NiMhurchu, F O'Kelly, I G Murphy, et al.
British Journal of Cancer|December 1, 1996
A study of ovarian cancer patients treated with dose-intensive chemotherapy supported with peripheral blood progenitor cells mobilised by filgrastim and cyclophosphamideA Weaver, E Wrigley, A Watson, et al.
The Journal of Laryngology and Otology|December 22, 1999
The diagnostic value of positron emission tomography (PET) with radiolabelled fluorodeoxyglucose (18F-FDG) in head and neck cancerN J Slevin, C D Collins, D L Hastings, et al.
Clinical Nephrology|September 1, 1996
Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritisP J Conlon, C A Fischer, M C Levesque, et al.
Pageof 14